Intrinsic role of chaperone-mediated autophagy in cancer stem cell maintenance

Jaione Auzmendi-Iriarte1, Ander Matheu1,2,3

  • 1Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain.

Autophagy
|April 25, 2022
PubMed

Insights

Chaperone-mediated autophagy (CMA) regulates glioblastoma stem cells. Inhibiting CMA reduces tumor growth and improves patient survival, revealing CMA as a therapeutic target in brain cancer.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Chaperone-mediated autophagy (CMA) is a selective protein degradation pathway.
  • The role of CMA in cancer stem cells (CSCs), particularly in glioblastoma, was previously unclear.

Purpose of the Study:

  • To investigate the expression and activity of CMA in glioblastoma stem cells (GSCs).
  • To determine the functional impact of CMA modulation on GSC behavior and glioblastoma progression.

Main Methods:

  • Characterization of LAMP2A expression and CMA activity in GSCs.
  • In vitro and in vivo experiments involving LAMP2A downregulation.
  • Proteomic and transcriptomic analyses to identify CMA-associated molecular pathways.
  • Correlation analysis of LAMP2 expression with clinical parameters in glioblastoma patients.

Main Results:

  • CMA is enriched in a subpopulation of GSCs.
  • Downregulation of LAMP2A (a key CMA component) inhibits GSC proliferation and self-renewal, induces apoptosis, and delays tumor progression in vivo.
  • CMA's molecular signature involves mitochondrial function, interferon pathways, and extracellular matrix interactions.
  • Increased LAMP2 expression in glioblastoma correlates with higher malignancy grade, temozolomide resistance, and poorer patient survival.

Conclusions:

  • CMA plays a critical role in regulating GSC tumorigenic properties.
  • CMA represents a novel therapeutic target for glioblastoma, with implications for improving patient outcomes.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K